Advances in ITP--therapy and quality of life--a patient survey.
BACKGROUND: Current guidelines recommend glucocorticoids and splenectomy as standard 1(st) and 2(nd) line treatments for chronic immune thrombocytopenia (ITP). We sought to find out how German ITP-patients are treated with respect to these guidelines. METHODS: Members of a patient support associatio...
Main Authors: | Axel C Matzdorff, Gabriele Arnold, Abdulgabar Salama, Helmut Ostermann, Sonja Eberle, Simone Hummler |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3214030?pdf=render |
Similar Items
-
Lenalidomide-Associated ITP
by: Christina I. Herold, et al.
Published: (2011-01-01) -
ITP following vaccination
by: Paula David, et al.
Published: (2020-10-01) -
The investigation of parents’ attending IEP conference and ITP conference and perceptions of IEP and ITP
by: Chiu-Ju Chi, et al.
Published: (2006) -
SARS-CoV-2 vaccination and ITP in patients with de novo or preexisting ITP
by: Al-Samkari, H., et al.
Published: (2022) -
ITP, Early Presentation of Thymoma
by: M Abbasi, et al.
Published: (2005-03-01)